Your browser doesn't support javascript.
loading
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
Randrian, Violaine; Pernot, Simon; Le Malicot, Karine; Catena, Vittorio; Baumgaertner, Isabelle; Tacher, Vania; Forestier, Julien; Hautefeuille, Vincent; Tabouret-Viaud, Claire; Gagnaire, Alice; Mitry, Emmanuel; Guiu, Boris; Aparicio, Thomas; Smith, Denis; Dhomps, Anthony; Tasu, Jean-Pierre; Perdrisot, Rémy; Edeline, Julien; Capron, Claude; Cheze-Le Rest, Catherine; Emile, Jean-François; Laurent-Puig, Pierre; Bejan-Angoulvant, Theodora; Sokol, Harry; Lepage, Come; Taieb, Julien; Tougeron, David.
Afiliación
  • Randrian V; Service d'Hépato-gastroentérologie, CHU de Poitiers et Université de Poitiers, Poitiers 86021, France.
  • Pernot S; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Le Malicot K; Fédération Francophone de Cancérologie Digestive, EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France.
  • Catena V; Department of Radiology, Institut Bergonié, Bordeaux, France.
  • Baumgaertner I; Department of Clinical Oncology, Henri-Mondor University Hospital, Créteil, France.
  • Tacher V; University of Paris Est Créteil, Unité INSERM 955, Equipe 18, AP-HP, Hôpitaux Universitaires Henri Mondor, Créteil F-94010, France.
  • Forestier J; Department of Medical Oncology, Hôpital Edouard Herriot, Lyon Cedex 03 69437, France.
  • Hautefeuille V; Department of Hepato-Gastroenterology and Digestive Oncology, Amiens University Hospital, Amiens, France.
  • Tabouret-Viaud C; Department of Nuclear Medicine, Unicancer-Georges François Leclerc Cancer Center, Dijon, France.
  • Gagnaire A; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, BP 87900 21079 Dijon, EPICAD LNC-UMR1231, Burgundy and Franche-Comte University, Dijon, France.
  • Mitry E; Medical Oncology Department, Paoli-Calmettes Institut, Marseille, France.
  • Guiu B; Hôpital St-Eloi (CHU Montpellier), Université de Montpellier, Montpellier, France.
  • Aparicio T; AP-HP, Gastroenterology and Digestive Oncology Department, Saint Louis Hospital, 1 avenue Claude Vellefaux, Université de Paris, Paris F-75010, France.
  • Smith D; Service d'Oncologie médicale, Haut-Lévèque Hospital, CHU Bordeaux, Bordeaux, France.
  • Dhomps A; Nuclear Medicine, University Hospital of Lyon, Pierre Bénite, France.
  • Tasu JP; Radiology Department, University Hospital Centre Poitiers, Poitiers, France; LATIM, INSERM UMR 1101, Université de Brest, CHU Morvan, 2 avenue FOCH, 29 609 Brest cedex, France.
  • Perdrisot R; Nuclear Medicine, Poitiers University Hospital, Poitiers France.
  • Edeline J; Medical Oncology, Centre Eugène Marquis, Rennes 35000, France.
  • Capron C; Service d'immunologie, AP-HP, Hôpital Ambroise Paré, Paris, France.
  • Cheze-Le Rest C; LATIM, INSERM UMR 1101, Université de Brest, CHU Morvan, 2 avenue FOCH, 29 609 Brest cedex, France; Nuclear Medicine, Poitiers University Hospital, Poitiers France.
  • Emile JF; Department of Pathology, APHP-Hôpital Ambroise Paré, Boulogne-Billancourt, France.
  • Laurent-Puig P; Department of Biology, Georges Pompidou Hospital, APHP, Université de Paris, Paris, France.
  • Bejan-Angoulvant T; Department of Medical Pharmacology, CHRU de Tours, Tours, France.
  • Sokol H; Sorbonne Université, INSERM UMRS-938, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, Service de Gastroentérologie, Paris, Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas and Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.
  • Lepage C; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, BP 87900 21079 Dijon, EPICAD LNC-UMR1231, Burgundy and Franche-Comte University, Dijon, France.
  • Taieb J; Service de Gastroentérologie et d'Oncologie Digestive, Hôpital Européen George Pompidou, Université de Paris, AP-HP, Paris, France.
  • Tougeron D; Service d'Hépato-gastroentérologie, CHU de Poitiers et Université de Poitiers, Poitiers 86021, France. Electronic address: david.tougeron@chu-poitiers.fr.
Dig Liver Dis ; 54(7): 857-863, 2022 07.
Article en En | MEDLINE | ID: mdl-35610167
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article